Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Comprehensive Vitreoretinopathy Panel PreventionGenetics, part of Exact Sciences United States | 26 | 21 |
|
Multiple Epiphyseal Dysplasia Panel PreventionGenetics, part of Exact Sciences United States | 29 | 10 |
|
Multiple Epiphyseal Dysplasia and Stickler Syndrome, Autosomal Recessive via the COL9A1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Central skeletal dysplasias panel. NGS panel of 111 genes. Genologica Medica Spain | 258 | 111 |
|
Cleft lip panel, cleft palate and associated syndromes. 16-gene NGS panel. Genologica Medica Spain | 49 | 16 |
|
Stickler syndrome panel. 8-gene NGS panel. Genologica Medica Spain | 30 | 8 |
|
Vitreoretinopathy panel. 23-gene NGS panel. Genologica Medica Spain | 63 | 23 |
|
Skeletal diseases. NGS panel of 169 genes. Genologica Medica Spain | 373 | 169 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 28 | 6 |
|
Connective Tissue Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 112 | 45 |
|
Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 5 | 4 |
|
Epiphyseal dysplasia, multiple: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 7 | 7 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Molecular Vision Laboratory United States | 36 | 19 |
|
Multiple epiphyseal dysplasia and pseudoachondroplasia Panel CeGaT GmbH Germany | 10 | 8 |
|
Multiple epiphyseal dysplasia due to collagen 9 anomaly type 6 Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.